Research ArticleArticle
Open Access
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein and Jürgen Braun
The Journal of Rheumatology December 2016, 43 (12) 2120-2130; DOI: https://doi.org/10.3899/jrheum.160420
Jonathan Kay
From the Division of Rheumatology, Department of Medicine, UMass Memorial Medical Center, and University of Massachusetts Medical School, Worcester, Massachusetts; Rheumatology, University of Texas Southwestern Medical Center and Metroplex Clinical Research Center, Dallas, Texas; Janssen Research and Development LLC, Spring House; University of Pennsylvania, Philadelphia, Pennsylvania,
USA; Division of Rheumatology, University of Toronto, Toronto, Ontario,
Canada; Rheumatology, Rheumazentrum Ruhrgebeit, Herne,
Germany.
Roy Fleischmann
Edward Keystone
Elizabeth C. Hsia
Benjamin Hsu
Yiying Zhou
Neil Goldstein
REFERENCES
- 1.↵
- Janssen BiotechInc
- 2.↵
- European Medicines Agency
- 3.↵
- AbbVie, Inc
- 4.↵
- UCB, Inc
- 5.↵
- Immunex Corporation
- 6.↵
- Janssen Biotech Inc
- 7.↵
- Kay J,
- Fleischmann R,
- Keystone E,
- Hsia EC,
- Hsu B,
- Mack M,
- et al.
- 8.↵
- Emery P,
- Fleischmann RM,
- Moreland LW,
- Hsia EC,
- Strusberg I,
- Durez P,
- et al.
- 9.
- Emery P,
- Fleischmann RM,
- Doyle MK,
- Strusberg I,
- Durez P,
- Nash P,
- et al.
- 10.↵
- Emery P,
- Fleischmann RM,
- Strusberg I,
- Durez P,
- Nash P,
- Amante E,
- et al.
- 11.↵
- Keystone EC,
- Genovese MC,
- Klareskog L,
- Hsia EC,
- Hall ST,
- Miranda PC,
- et al.
- 12.
- Keystone E,
- Genovese MC,
- Klareskog L,
- Hsia EC,
- Hall S,
- Miranda PC,
- et al.
- 13.
- Keystone EC,
- Genovese MC,
- Hall S,
- Miranda PC,
- Bae SC,
- Palmer W,
- et al.
- 14.↵
- Keystone EC,
- Genovese MC,
- Hall S,
- Bae SC,
- Han C,
- Gathany TA,
- et al.
- 15.↵
- Smolen JS,
- Kay J,
- Doyle MK,
- Landewé R,
- Matteson EL,
- Wollenhaupt J,
- et al;
- GO-AFTER study investigators
- 16.
- Smolen JS,
- Kay J,
- Landewé RB,
- Matteson EL,
- Gaylis N,
- Wollenhaupt J,
- et al.
- 17.↵
- Smolen JS,
- Kay J,
- Doyle M,
- Landewé R,
- Matteson EL,
- Gaylis N,
- et al.
- 18.↵
- Kavanaugh A,
- McInnes I,
- Mease P,
- Krueger GG,
- Gladman D,
- Gomez-Reino J,
- et al.
- 19.↵
- 20.↵
- Kavanaugh A,
- McInnes IB,
- Mease PJ,
- Krueger GG,
- Gladman DD,
- van der Heijde D,
- et al.
- 21.↵
- Kavanaugh A,
- McInnes IB,
- Mease P,
- Krueger GG,
- Gladman D,
- van der Heijde D,
- et al.
- 22.↵
- 23.↵
- Braun J,
- Deodhar A,
- Inman RD,
- van der Heijde D,
- Mack M,
- Xu S,
- et al.
- 24.↵
- Deodhar A,
- Braun J,
- Inman RD,
- van der Heijde D,
- Zhou Y,
- Xu S,
- et al.
- 25.↵
- 26.↵
- 27.↵
- 28.↵National Cancer Institute: Surveillance, Epidemiology, and End Results. Overview of the SEER program. [Internet. Accessed September 6, 2016.] Available from: SEER.cancer.gov/about/overview.html
- 29.↵
- 30.↵
- Furst DE,
- Kavanaugh A,
- Florentinus S,
- Kupper H,
- Karunaratne M,
- Birbara CA
- 31.↵
- 32.↵
- Baecklund E,
- Ekbom A,
- Sparén P,
- Feltelius N,
- Klareskog L
- 33.↵
- 34.↵
In this issue
The Journal of Rheumatology
Vol. 43, Issue 12
1 Dec 2016
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, Jürgen Braun
The Journal of Rheumatology Dec 2016, 43 (12) 2120-2130; DOI: 10.3899/jrheum.160420
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis
Jonathan Kay, Roy Fleischmann, Edward Keystone, Elizabeth C. Hsia, Benjamin Hsu, Yiying Zhou, Neil Goldstein, Jürgen Braun
The Journal of Rheumatology Dec 2016, 43 (12) 2120-2130; DOI: 10.3899/jrheum.160420